Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Aug 30:14:1237845.
doi: 10.3389/fphar.2023.1237845. eCollection 2023.

Protective effect of phytoestrogens on nonalcoholic fatty liver disease in postmenopausal women

Affiliations
Review

Protective effect of phytoestrogens on nonalcoholic fatty liver disease in postmenopausal women

ChenLu Zhao et al. Front Pharmacol. .

Abstract

Non-alcoholic fatty liver disease (NAFLD) is a progressive metabolic disease characterized by hepatic steatosis, inflammation, and fibrosis that seriously endangers global public health. Epidemiological studies have shown that the incidence of non-alcoholic fatty liver disease in postmenopausal women has significantly increased. Studies have shown that estrogen deficiency is the main reason for this situation, and supplementing estrogen has become a new direction for preventing the occurrence of postmenopausal fatty liver. However, although classical estrogen replacement therapy can reduce the incidence of postmenopausal NAFLD, it has the risk of increasing stroke and cardiovascular diseases, so it is not suitable for the treatment of postmenopausal NAFLD. More and more recent studies have provided evidence that phytoestrogens are a promising method for the treatment of postmenopausal NAFLD. However, the mechanism of phytoestrogens in preventing and treating postmenopausal NAFLD is still unclear. This paper summarizes the clinical and basic research evidence of phytoestrogens and reviews the potential therapeutic effects of phytoestrogens in postmenopausal NAFLD from six angles: enhancing lipid metabolism in liver and adipose tissue, enhancing glucose metabolism, reducing oxidative stress, reducing the inflammatory response, regulating intestinal flora, and blocking liver fibrosis (Graphical Abstract).

Keywords: glucose metabolism; inflammatory response; intestinal flora; lipid metabolism; non-alcoholic fatty liver disease; oxidative stress; phytoestrogens(PEs); postmenopausal women.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

FIGURE 1
FIGURE 1
Molecular structure of phytoestrogens.
FIGURE 2
FIGURE 2
The mechanism of phytoestrogens regulating liver lipid metabolism.
FIGURE 3
FIGURE 3
The mechanism of phytoestrogens in alleviating liver inflammatory response.
FIGURE 4
FIGURE 4
Role of phytoestrogens in postmenopausal NAFLD.

Similar articles

References

    1. Amanat S., Eftekhari M. H., Fararouei M., Bagheri Lankarani K., Massoumi S. J. (2018). Genistein supplementation improves insulin resistance and inflammatory state in non-alcoholic fatty liver patients: A randomized, controlled trial. Clin. Nutr. 37, 1210–1215. 10.1016/j.clnu.2017.05.028 - DOI - PubMed
    1. Baeza I., Fdez-Tresguerres J., Ariznavarreta C., De la Fuente M. (2010). Effects of growth hormone, melatonin, oestrogens and phytoestrogens on the oxidized glutathione (GSSG)/reduced glutathione (GSH) ratio and lipid peroxidation in aged ovariectomized rats. Biogerontology 11, 687–701. 10.1007/s10522-010-9282-7 - DOI - PubMed
    1. Bessone F., Razori M. V., Roma M. G. (2019). Molecular pathways of nonalcoholic fatty liver disease development and progression. Cell Mol. Life Sci. 76, 99–128. 10.1007/s00018-018-2947-0 - DOI - PubMed
    1. Böttner M., Christoffel J., Wuttke W. (2008). Effects of long-term treatment with 8-prenylnaringenin and oral estradiol on the GH-IGF-1 axis and lipid metabolism in rats. J. Endocrinol. 198, 395–401. 10.1677/JOE-08-0127 - DOI - PubMed
    1. Braxas H., Rafraf M., Karimi Hasanabad S., Asghari Jafarabadi M. (2019). Effectiveness of genistein supplementation on metabolic factors and antioxidant status in postmenopausal women with type 2 diabetes mellitus. Can. J. Diabetes 43, 490–497. 10.1016/j.jcjd.2019.04.007 - DOI - PubMed

Grants and funding

This research was funded by the National Natural Science Foundation of China (Nos 81473651, 81904161), Construction Project of Characteristic Backbone Discipline of Traditional Chinese Medicine in Henan Province (STG-ZYXKY-2020024).

LinkOut - more resources